Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

d-Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner.

Svane KC, Asis EK, Omelchenko A, Kunnath AJ, Brzustowicz LM, Silverstein SM, Firestein BL.

Mol Cell Neurosci. 2018 Jun;89:20-32. doi: 10.1016/j.mcn.2018.03.011. Epub 2018 Mar 27.

PMID:
29601869
2.

QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors.

Spellmann I, Reinhard MA, Veverka D, Zill P, Obermeier M, Dehning S, Schennach R, Müller N, Möller HJ, Riedel M, Musil R.

Eur Arch Psychiatry Clin Neurosci. 2018 Jun;268(4):383-390. doi: 10.1007/s00406-018-0880-8. Epub 2018 Feb 10.

PMID:
29429138
3.

The interaction of NOS1AP, DISC1, DAOA, and GSK3B confers susceptibility of early-onset schizophrenia in Chinese Han population.

Hu G, Yang C, Zhao L, Fan Y, Lv Q, Zhao J, Zhu M, Guo X, Bao C, Xu A, Jie Y, Jiang Y, Zhang C, Yu S, Wang Z, Li Z, Yi Z.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:187-193. doi: 10.1016/j.pnpbp.2017.10.017. Epub 2017 Oct 31.

PMID:
29100974
4.

Research progress in NOS1AP in neurological and psychiatric diseases.

Wang J, Jin L, Zhu Y, Zhou X, Yu R, Gao S.

Brain Res Bull. 2016 Jul;125:99-105. doi: 10.1016/j.brainresbull.2016.05.014. Epub 2016 May 26. Review.

PMID:
27237129
5.

Overexpression of Isoforms of Nitric Oxide Synthase 1 Adaptor Protein, Encoded by a Risk Gene for Schizophrenia, Alters Actin Dynamics and Synaptic Function.

Hernandez K, Swiatkowski P, Patel MV, Liang C, Dudzinski NR, Brzustowicz LM, Firestein BL.

Front Cell Neurosci. 2016 Feb 2;10:6. doi: 10.3389/fncel.2016.00006. eCollection 2016.

6.

Interaction of NOS1AP with the NOS-I PDZ domain: Implications for schizophrenia-related alterations in dendritic morphology.

Candemir E, Kollert L, Weißflog L, Geis M, Müller A, Post AM, O'Leary A, Harro J, Reif A, Freudenberg F.

Eur Neuropsychopharmacol. 2016 Apr;26(4):741-55. doi: 10.1016/j.euroneuro.2016.01.008. Epub 2016 Jan 28.

PMID:
26861996
7.

Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study.

Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.

Schizophr Res. 2016 Jan;170(1):30-40. doi: 10.1016/j.schres.2015.11.008. Epub 2015 Nov 18. Review.

8.

Association of NOS1AP variants and depression phenotypes in schizophrenia.

Cheah SY, Lawford BR, Young RM, Morris CP, Voisey J.

J Affect Disord. 2015 Dec 1;188:263-9. doi: 10.1016/j.jad.2015.08.069. Epub 2015 Sep 8.

PMID:
26384012
9.

Unexpected Heterodivalent Recruitment of NOS1AP to nNOS Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models.

Li LL, Melero-Fernandez de Mera RM, Chen J, Ba W, Kasri NN, Zhang M, Courtney MJ.

J Neurosci. 2015 May 13;35(19):7349-64. doi: 10.1523/JNEUROSCI.0037-15.2015.

10.

Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders.

Freudenberg F, Alttoa A, Reif A.

Genes Brain Behav. 2015 Jan;14(1):46-63. doi: 10.1111/gbb.12193. Review.

11.

Nitric oxide synthase 1 adaptor protein, a protein implicated in schizophrenia, controls radial migration of cortical neurons.

Carrel D, Hernandez K, Kwon M, Mau C, Trivedi MP, Brzustowicz LM, Firestein BL.

Biol Psychiatry. 2015 Jun 1;77(11):969-78. doi: 10.1016/j.biopsych.2014.10.016. Epub 2014 Oct 30.

12.

Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling.

Courtney MJ, Li LL, Lai YY.

Front Cell Neurosci. 2014 Aug 27;8:252. doi: 10.3389/fncel.2014.00252. eCollection 2014. Review.

13.

The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis.

Weber H, Klamer D, Freudenberg F, Kittel-Schneider S, Rivero O, Scholz CJ, Volkert J, Kopf J, Heupel J, Herterich S, Adolfsson R, Alttoa A, Post A, Grußendorf H, Kramer A, Gessner A, Schmidt B, Hempel S, Jacob CP, Sanjuán J, Moltó MD, Lesch KP, Freitag CM, Kent L, Reif A.

Eur Neuropsychopharmacol. 2014 Jan;24(1):65-85. doi: 10.1016/j.euroneuro.2013.09.005. Epub 2013 Sep 27.

PMID:
24220657
14.

The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death.

Li LL, Ginet V, Liu X, Vergun O, Tuittila M, Mathieu M, Bonny C, Puyal J, Truttmann AC, Courtney MJ.

J Neurosci. 2013 May 8;33(19):8185-201. doi: 10.1523/JNEUROSCI.4578-12.2013.

15.

[Association of Schizophrenia and its Clinical Implications with the NOS1AP Gene in the Colombian Population].

Valencia JG, Duarte AV, Vila AL, Kremeyer B, Montoya MP, Linares AR, Acosta CA, Duque JO, Berrío GB.

Rev Colomb Psiquiatr. 2012 Jun;41(2):249-72. doi: 10.1016/S0034-7450(14)60003-2. Epub 2014 May 10. Spanish.

PMID:
26573492
16.

Early environmental exposures influence schizophrenia expression even in the presence of strong genetic predisposition.

Husted JA, Ahmed R, Chow EW, Brzustowicz LM, Bassett AS.

Schizophr Res. 2012 May;137(1-3):166-8. doi: 10.1016/j.schres.2012.02.009. Epub 2012 Mar 3.

17.

Genome-wide association study of antipsychotic-induced QTc interval prolongation.

Aberg K, Adkins DE, Liu Y, McClay JL, Bukszár J, Jia P, Zhao Z, Perkins D, Stroup TS, Lieberman JA, Sullivan PF, van den Oord EJ.

Pharmacogenomics J. 2012 Apr;12(2):165-72. doi: 10.1038/tpj.2010.76. Epub 2010 Oct 5.

18.

Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

Nicodemus KK, Law AJ, Radulescu E, Luna A, Kolachana B, Vakkalanka R, Rujescu D, Giegling I, Straub RE, McGee K, Gold B, Dean M, Muglia P, Callicott JH, Tan HY, Weinberger DR.

Arch Gen Psychiatry. 2010 Oct;67(10):991-1001. doi: 10.1001/archgenpsychiatry.2010.117.

19.

Reduced gray matter in the anterior cingulate gyrus in familial schizophrenia: a preliminary report.

Costain G, Ho A, Crawley AP, Mikulis DJ, Brzustowicz LM, Chow EW, Bassett AS.

Schizophr Res. 2010 Sep;122(1-3):81-4. doi: 10.1016/j.schres.2010.06.014. Epub 2010 Jul 16.

20.

NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia.

Hadzimichalis NM, Previtera ML, Moreau MP, Li B, Lee GH, Dulencin AM, Matteson PG, Buyske S, Millonig JH, Brzustowicz LM, Firestein BL.

Schizophr Res. 2010 Dec;124(1-3):248-50. doi: 10.1016/j.schres.2010.05.009. Epub 2010 Jun 1. No abstract available.

Supplemental Content

Loading ...
Support Center